Table 1 Patient clinical and demographic information
From: Patient-reported treatment burden of chronic immune thrombocytopenia therapies
All patients | ||
|---|---|---|
n | Percentage | |
Total | 589 | 100% |
Demographics | ||
Age (Mean (SD)) | 47.74 (14.71) | |
18-24 | 32 | 5.4% |
25-34 | 96 | 16.3% |
35-44 | 122 | 20.7% |
45-54 | 134 | 22.8% |
55-64 | 133 | 22.6% |
65-74 | 51 | 8.7% |
75+ | 21 | 3.6% |
Race/Ethnicity (multiple response) | ||
White, not of Hispanic origin | 521 | 88.5% |
Hispanic | 27 | 4.6% |
Black, not of Hispanic origin | 23 | 3.9% |
Asian or Pacific Islander | 12 | 2.0% |
American Indian/Alaskan Native | 8 | 1.4% |
Employment | ||
Employed--Full time | 284 | 48.2% |
Employed--Part time | 77 | 13.1% |
Self-Employed | 38 | 6.5% |
Unemployed | 190 | 32.3% |
Patient symptoms and clinical characteristics | ||
Wet Bleeds (Nose or mouth bleeds (in past year)) | ||
Not at all | 317 | 53.8% |
Once or twice | 193 | 32.8% |
Once a month or up to 12 times | 54 | 9.2% |
More than once a month | 25 | 4.2% |
Dry Bleeds (bruising, hematomas, or petechiae (in past year)) | ||
Not at all | 122 | 20.7% |
Once or twice | 149 | 25.3% |
Once a month or up to 12 times | 132 | 22.4% |
More than once a month | 186 | 31.6% |